The Russian Ministry of Health approved Esperavir®️, a new drug for coronavirus
Promomed 04 February 2022
«Segodnya» (Today) TV program on the NTV channel showed a broadcast about approval of a new drug for the treatment of coronavirus infection, Esperavir®️ by Promomed Group.
Esperavir®️ has successfully passed all stages of clinical studies. They started in December last year and took place at 16 clinical sites across the country. Also, according to the results of studies, it was demonstrated that Esperavir®️ is ahead of the coronavirus mutation, which gains time for treatment.
The drug will be produced in Mordovia, production will start in a week.
